ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

KMPH KemPharm Inc

5.81
0.00 (0.00%)
Mar 27 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0
Bid Price 5.79
Ask Price 5.88
News -
Company Name Stock Ticker Symbol Market Type
KemPharm Inc KMPH NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 5.81 20:00:00
Open Price Low Price High Price Close Price Prev Close
5.81 5.81
Trades Volume Avg Volume
0 0 -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 5.81 USD

KemPharm Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
200.68M 34.54M - 10.46M -41.54M -1.20 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

KemPharm News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No KMPH Message Board. Create One! See More Posts on KMPH Message Board See More Message Board Posts

Historical KMPH Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years9.2815.69674.008.21458,329-3.47-37.39%
5 Years1.7218.150.185.73965,7974.09237.79%

KemPharm Description

KemPharm Inc is a clinical-stage specialty pharmaceutical company engaged in the discovery and development of treatments for the central nervous system, CNS, and rare disease indications. The company uses its Ligand Activated Therapy (LAT) platform technology to create prodrugs. Its LAT platform technology discovers and develops prodrugs that improve one or more of the attributes of approved drugs, such as susceptibility to abuse, bioavailability, and safety.

Your Recent History

Delayed Upgrade Clock